Shots:

• The app will record pain relief during the device trial period with SCS or DRG therapy- simplifying reporting outcomes & connect patients to physicians who have real-time access to the data
• The app will be compatible with Abbott's Proclaim XR SCS system for patients living with chronic pain in the trunk & limbs and Proclaim DRG neurostimulation system for patients with chronic pain in the lower limbs
• The app will allow patients to use their Apple phone to connect with Abbott support- access educational resources & track the progress of their trial pain relief journey. The app will be available on the Apple app store in the coming weeks and is expected to be available on android devices in Q2’21

Click here to­ read full press release/ article 

Ref: PRNewswire | Image: Abbott